Bound Therapeutics | News | 252nd American Chemical Society National Meeting

252nd American Chemical Society National Meeting

August 24, 2016

Written by

Contact

info@boundtherapeutics.com

Share it

Others Press Release

September 29, 2025

Bound Therapeutics Closes First Round of Pre-Seed Financing, Bringing Total Funding to $3.4M

June 14, 2019

RNA Blockade to Treat Triple Negative Breast Cancer

News

September 10, 2018

Bound Therapeutics is selected as a finalist in the UC Science Center QED proof-of-concept program

News